Abstract
From the early years of the introduction of H2 antagonists for clinical uses, many reports have been published that H2 antagonists induce various kinds of cytopenia, such as neutropenia, agranulocytosis, thrombocytopenia, pancytopenia and lymphopenia. At the present time, it has become evident that histamine exerts a stimulative effect on the differentiation and proliferation of bone marrow stem cells, especially in neutrophil progenitors, via an H2 receptor stimulation (Tasaka, 1991). However, as early as 8 years before the discovery of the H2 receptor and histamine H2 antagonist by Black et al. (1972), Tasaka and Code (1964) reported that chronic injection of histamine induces leukocytosis in various kinds of experimental animals. This was the first report which clearly pointed out the hematopoietic action of histamine in vivo. A growing body of evidence indicates that histamine is not only a physiological hematopoietic substance but also that it interacts with other hematopoietic cytokines, such as granulocytic colony stimulating factor (G-CSF) and interleukin-1α (IL-1), at physiological concentration range. The stimulative effect of histamine on several leukemia cells has also been reported (Nonaka et al., 1992). In this chapter, the mechanism of histamine-induced leukocytosis is reviewed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adachi K., Aoyagi T., Iizuka H., Halprin K.M. and Levine V. (1980) Cyclic GMP system in the epidermis. Curr. Probl. Dermatol., 10: 39–65
Akiyama Y., Mukai T., Kamei C. and Tasaka K. (1990) Histamine lipolysis I: Changes in the free fatty acid levels of dog plasma after intravenous infusion of histamine. Meth. Find. Exp. Clin. Pharmacol., 12: 315–324
Bainton D.F., Ullyot J.L. and Farquhar M.G. (1971) The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J. Exp. Med., 134: 907–934
Black J.W., Duncan W.A.M., Durant G.J., Gannelin C.R. and Parsons M.E.: Definition and antagonism of histamine H2-receptors. Nature, 236: 385–390
Burgess A.W. and Metcalf D. (1980) The nature and action of granulocyte-macrophage colony stimulating factors. Blood, 56: 947–958
Burtin C. (1986) Mast cells and tumour growth. Ann. Inst. Pasteur Immunol., 137D: 289–294
Burtin C., Scheinmann P., Salomon J.C., Lespinats G., Frayssinet C., Lebel B. and Canu P. (1981) Increased tissue histamine in tumour-bearing mice and rats. Br. J. Cancer, 43: 684–688
Byron J.W. (1976) Bone-marrow toxicity of metiamide. Lancet, 2: 1350
Byron J.W. (1980) Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFU-S). Exp. Hematol., 8: 256–263
Catini C., Gheri G., Giampaoli M. and Miliani A. (1984) Histamine uptake by leukocytes in vitro. Basic Appl. Histochem., 28: 329–336
Chaplinski T.J. and Niedel J.E. (1986) Cyclic AMP levels and cellular kinetics during maturation of human promyelocytic leukemia cell. J. Leukocyte Biol., 39: 323–331
Clark R.A.F., Gallin J.I. and Kaplan A. (1975) The selective eosinophil chemotactic activity of histamine. J. Exp. Med., 142: 1462–1476
Code C.F. (1976) Suppression of histamine leucocytosis by metiamide. J. Physiol. (Lond.) 254: 31P-32P
Collins S.J., Ruscetti F.W., Gallagher R.E. and Gallo R.C. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA, 75: 2458–2462
de Galoscy C. and van Ypersele de Strihou C. (1979) Pancytopenia with cimetidine. Ann. Intern. Med., 90: 274
Deutsch P.J., Rosen O.M. and C.S. Rubin (1982) Identification and characterization of a latent pool of insulin receptors in 3T3-L1 adipocytes. J. Biol. Chem., 257: 5350–5358
Dexter T.M., Allen T.D. and Lajtha L.G. (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol., 91: 335–344
Dexter T.M. and Testa N.G. (1976) Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol. 14: 387–405
Dinarello C.A. (1988) Interleukin-1. Ann. N.Y. Acad. Sci., 546: 122–132
Dinarello C.A., Ikejima T., Warner S.J.C., Orencole S.F., Lonnemann G., Cannon J.G. and Libby P. (1987) Interleukin 1 induces interleukin 1. J. Immunol., 139: 1902–1910
Dunn A.R. (1987) The role of growth factors in normal and neoplastic haemopoiesis. Ann. N. Y. Acad. Sci. 511: 1–9
Evans S.W., Rennick D. and Farrar W.L. (1987) Identification of a signal-transduction pathway shared by haematopoietic growth factors with diverse biological specificity. Biochem. J., 244: 683–691
Feldman E.J. and Isenberg J.I. (1976) Effects of metiamide on gastric acid hypersecretion, steatorrhea and bone-marrow function in a patient with systemic mastocytosis. N. Engl. J. Med., 295: 1178–1179
Fibbe W.E., Damme J.V., Billiau A., Goselink H.M., Voogt P.J., Eeden G.V., Ralph P., Altrock B.W. and Falkenburg J.H.F. (1988) Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 71: 430–435
Fleming W.A. and McNeill T.A. (1976) Cellular responsiveness to stimulation in vitro. Increased responsiveness to colony stimulating factor of bone marrow colony forming cells treated with surface active agents and cyclic 3′, 5′AMP. J. Cell Physiol. 88: 323–330
Forrest J.A.H., Shearman D.J.C., Spence R. and Celestin L.R. (1975) Neutropenia associated with metiamide. Lancet, 1: 392–393
Gespach C., Saal F., Cost H. and Abita J.P. (1982) Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. Mol. Pharmacol., 22: 547–553
Gespach C., Marrec N. and Belitrand N. (1985a) Relationship between 3H-histamine uptake and H2-receptors in the human promyelocytic leukemia cell line HL-60. Agents Actions, 16: 279–283
Gespach C., Cost H. and Abita J.-P. (1985b) Histamine H2 receptor activity during the differentiation of the human monocytic-like cell line U-937. Comparison with prostaglandins and isoproterenol. FEBS Lett., 184: 207–213
Gespach C., Courillon-Mallet A., Launay J.M., Cost H. and Abita J.-P. (1986b) Histamine H2 receptor activity and histamine metabolism in human U-937 monocyte-like cells and human peripheral monocytes. Agents Actions, 18: 124–128
Gowda S.D., Koler R.D. and Bagby G.C. Jr. (1986) Regulation of c-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells. J. Clin. Invest., 77: 271–278
Graham H.T., Lowry O.H., Wheelwright F., Lenz M.A. and Parish H.H. Jr. (1955) Distribution of histamine among leukocytes and platelets. Blood, 10: 467–481
Harper R.A., Flaxman B.A. and Chopra D.P. (1974) Mitotic response of normal and psoriatic keratinocytes in vitro to compounds known to affect intracellular cAMP. J. Invest. Dermatol., 62: 384–387
Hatamochi A., Fujiwara K. and Ueki H. (1985) Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch. Dermatol. Res., 277: 60–64
Hay L.J., Vacro R.L., Code C.F. and Wangensteen O.H. (1942) The experimental production of gastric and duodenal ulcers in laboratory animals by the intramuscular injection of histamine in beeswax. Surg. Gynecol. Obstet., 75: 170–182
Hidaka H., Inagaki M., Kawamoto S. and Sakai Y. (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry, 23: 5036–5041
Idvall J. (1979) Cimetidine-associated thrombocytopenia. Lancet, 2: 159
Iizuka H., Adachi K., Halprin K.M. and Levine V. (1978) Cyclic AMP accumulation in psoriatic skin: differential responses to histamine. AMP and epinephrine by the uninvolved and involved epidermis. J. Invest. Dermatol., 70: 250–253
Imaizumi, M. and Breitman, T.R. (1988) Changes in c-myc, c-fms and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia. Cancer Res., 48: 6733–6738
Johnson M.McI., Black A.E., Hughes A.S.B. and Clarke S.W. (1977) Leucopenia with cimetidine. Lancet, 2: 1226–1227
Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A. and Kaneko M. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun., 142: 436–440
Kiss Z., Deli E., Vogler W.R. and Kuo J.F. (1987) Anti-leukemic agent alkyllysophospholipid regulates phosphorylation of distinct proteins in HL-60 and K-562 cells and differentiation of HL-60 cells prompted by phorbol ester. Biochem. Biophys. Res. Commun., 42: 661–666
Klotz S.A. and Kay B.F. (1978) Cimetidine and agranulocytosis. Ann. Intern. Med., 88: 579–580
Knight D.E. and Scrutton M.C. (1984) Cyclic nucleotides control a system which regulates Ca2+ sensitivity of platelet secretion. Nature, 309: 66–68
Kobayasi Y., Appella E., Yamada M., Copeland T.D., Oppenheim J.J. and Matsushima K. (1988) Phosphorylation of intracellular receptors of human IL-1. J. Immunol., 140: 2279–2287
Koeffler H.P. (1983) Induction of differentiation of human acute myelogenious leukemia cells: Therapeutic implications. Blood, 62: 709–721
Lanotte M., Metcalf D. and Dexter T.M. (1982) Production of monocyte/macrophage colony- stimulating factor by preadipocyte cell lines derived from murine marrow stroma. J. Cell. Physiol., 112: 123–127
Liebermann D.A. and Hoffman-Liebermann B. (1989) Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene, 4: 583–592
Lin H.-S., Lokekshwar B.L. and Hsu J.R. (1989) Both granulocyte-macrophage CSF and macrophage CSF control the proliferation and survival of the same subset of alveolar macrophages. J. Immunol., 142: 515–519
Lingberg S. and Tönqvist Å. (1966) The inhibitory effect of aminoguanidine on histamine catabolism in human pregnancy. Acta Obstet. Gynecol. Scand., 45: 131–139
Lotem J. and Sachs L. (1987) Regulation of cell-surface receptors for hematopoietic differentiation-inducing protein MGI-2 on normal and leukemic myeloid cells. Int. J. Cancer, 40: 532–539
Marks R.M., Roche W.R., Czemiecki M., Penny R. and Nelson D.S. (1986) Mast cell granules cause proliferation of human micro vascular endothelial cells. Lab. Invest., 55: 289–294
Maslinski C.Z., Kierska D., Sasiak K. and Adamas B. (1984) Histamine and its catabolism in tumor-bearing rat and mouse. Agents Actions, 14: 497–500
McCachren S.S. Jr., Nichols J., Kaufman R.E. and Niedel J.E. (1986) Dibutyric cyclic adenosine monophosphate reduces expression of c-myc during HL-60 differentiation. Blood, 68: 412–416
Mochizuki D.Y., Eisenman J.R., Conlon P.J., Larsen A.D. and Tushinski R.J. (1987) Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc. Natl. Acad. Sci. USA 84: 5267–5271
Nakao S., Matsushima K. and Young N. (1989) Decreased interleukin 1 production in aplastic anaemia. Br. J. Haematol., 71: 431–436
Nakaya N. and Tasaka K. (1988a) The influence of histamine on precursors of granulocytic leukocytes in murine bone marrow. Life Sci., 42: 999–1010
Nakaya N. and Tasaka K. (1988b) Histamine incorporation into murine myeloblasts and promyelocytes. Formation of a histamine transport system. Biochem. Pharmacol., 37: 4523–4530
Nicola N.A., Peterson L., Hilton D.J. and Metcalf D. (1988) Cellular processing of murine colony-stimulating factor (multi-CSF, GM-CSF, G-CSF) receptors by normal hemopoietic cells and cell lines. Growth Factors, 1, 41–49
Nomura H., Imazeki I., Oheda M., Kubota N., Tamura M., Ono M., Ueyama Y. and Asano S. (1986) Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J., 5: 871–876
Nonaka T., Mio M., Doi M. and Tasaka K. (1992) Histamine-induced differentiation of HL-60 cells. The role of cAMP and protein kinase A. Biochem. Pharmacol., 44: 1115–1121
Ohta Y., Akiyama T., Nishida E. and Sakai H. (1987) Protein kinase C and c AMP- dependent protein kinase induce opposite effects on actin polymerizability. FEBS Lett, 222: 305–310
Platzer E., Simon S. and Kalden J.R. (1988) Human granulocyte colony stimulating factor: Effects of human long-term bone marrow cultures. Blood Cells, 14: 463–469
Plet A., Evain D. and Anderson W.B. (1982) Effect of retinoic acid treatment of F9 embryonal carcinoma cells on the activity and distribution of cAMP dependent protein kinase. J. Biol. Chem., 257: 889–893
Radermecker M. and Maldague M.-P. (1981) Depression of neutrophil chemotaxis in atopic individuals. An H2 histamine receptor response. Int. Arch. Allergy Appl. Immunol., 65: 144–152
Rapoport A.P., Abboud C.N. and DiPersio J.F. (1992) Granulocyte-macrophage colony- stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): Receptor biology, signal transduction, and neutrophil activation. Blood Rev., 6: 43–57
Rocklin R.E. and Haberek-Davidson A. (1981) Histamine activates suppressor cells in vitro using a coculture technique. J. Clin. Immunol., 1: 73–79
Rocklin R.E., Greineder D. and Melmon K.L. (1979) Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. Cell. Immunol., 44: 404–415
Rosenwasser L.J. and Dinarello C.A. (1981) Ability of human leukocytic pyrogen to enhance hemagglutinin induced murine thmocyte proliferation. Cell. Immunol., 63: 134–142
Salehi Z., Taylor J.D. and Niedel J.E. (1988) Dioctanoylglycerol and phorbol esters regulate transcription of c-myc in human promyelocytic leukemia cells. J. Biol. Chem., 263: 1898–1903
Sawutz D.G., Kalinyak K., Whitsett J.A., Johnson C.L. (1984) Histamine H2-receptor desensitization in HL-60 human promyelocytic leukemia cells. J. Pharmacol. Exp. Ther., 231: 1–7
Schwartz J.-C., Arrang J.-M., Bouthenet M.-L., Garbarg M., Pollard H. and Raut M. (1991) Histamine receptors in brain, in ‘Handbook of Experimental Pharmacology, vol. 97. Histamine and histamine antagonists’ (ed. Uväns B.), Springer-Verlag, Berlin, pp. 191–242
Spotts G.D. and Hann S.R. (1990) Enhanced translocation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol. Cell. Biol., 10: 3952–3964
Tasaka K. (1991) Histamine and the Blood, in ‘Handbook of Experimental Pharmacology, vol. 97. Histamine and histamine antagonists’ (ed. Uvnäs B.), Springer-Verlag, Berlin, pp. 473–510
Tasaka K. and Code C.F. (1964) Histamine leukocytosis. Fed. Proc. 23: 471
Tasaka K. and Nakaya N. (1987) The relationship between incorporation of histamine and differentiation of neutrophil progenitors in murine bone marrow. Agents Actions, 20: 320–323
Tasaka K., Nakaya N. and Code C.F. (1992a) Histamine leukocytosis. I. Effect of histamine on peripheral leukocyte counts. Meth. Find. Exp. Clin. Pharmacol., 14: 667–675
Tasaka K., Shorter R.G. and Code C.F. (1992b) Histamine leukocytosis. II. Source of histamine leukocytosis. Meth. Find. Exp. Clin. Pharmacol., 14: 799–804
Tasaka K., Mio M., Shimazawa M. and Nakaya N. (1993) Histamine-induced production of interleukin-lor from murine bone marrow stromal cells and its inhibition by H2 blockers. Mol. Pharmacol., 43: 365–371
Tasaka K., Doi M., Nakaya N. and Mio M. (1994) Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: Extemalization of G-CSF receptors induced by histamine. Mol. Pharmacol., 45: 837–845
Voorhees J.J., Duell E.A., Bass L.J., Powell J.A. and Harrell E.R. (1972) The cyclic AMP system in normal and psoriatic epidermis. J. Invest. Dermatol.,59: 114–120
Walker F., Nicola N.A., Metcalf D. and Burgess A.W. (1985) Hierarchical down-modulation of hemopoietic growth factor receptors. Cell, 43: 269–276
Zsebo K.M., Yuschenkoff V.N., Schiffer S., Chang D., McCall E., Dinarello C.A., Brown M.A., Altrock B. and Bagby G.C. (1988) Vascular endothelial cells and granulopoiesis: Interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 71: 99–103
Zucali J.R., Dinarello C.A., Obion D.J., Gross M.A., Anderson L. and Weiner R.S. (1986) Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J. Clin. Invest., 77: 1857–1863
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Tasaka, K. (1994). Histamine-induced leukocytosis. In: New Advances in Histamine Research. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68263-9_8
Download citation
DOI: https://doi.org/10.1007/978-4-431-68263-9_8
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68265-3
Online ISBN: 978-4-431-68263-9
eBook Packages: Springer Book Archive